There is no optimal method for the treatment of community-acquired pneumonia, and the most commonly used treatments include anti-infective therapy, and symptomatic supportive therapy.
Community-acquired pneumonia is mostly caused by bacterial, mycoplasma, chlamydia, viral, fungal and other infections. Physical and chemical stimulation and immune damage can also lead to pneumonia, and the treatment mainly needs to clarify the cause of the disease as early as possible and give targeted treatment.
1. Bacterial infections: for penicillin-sensitive Streptococcus pneumoniae infections, penicillin G, penicillin V or amoxicillin can be selected; Haemophilus influenzae infections can be selected from the second and third generation of cephalosporins; anaerobic infections can be selected from the clindamycin and metronidazole drug therapy.
2. Mycoplasma and Chlamydia infections: macrolide antibiotics, such as azithromycin and erythromycin, need to be applied.
3. Viral infections: generally not recommended to give antiviral treatment, symptomatic treatment can be; for fungal infections need to apply fluconazole, itraconazole and so on.
4. Symptomatic supportive treatment: for patients with diagnosed high fever, antipyretic and analgesic drugs, such as acetaminophen, aspirin, ibuprofen, etc.; for those with thick sputum, expectorant drugs, such as aminoglutethimide and bromhexine, are recommended; for those with severe coughing, no sputum or little sputum, which affects the rest seriously, dextromethorphan and phenprocodone can be used to suppress coughing temporarily.
It is recommended that patients with community pneumonia should consult a doctor in time to identify the cause and standardize the treatment under the doctor’s guidance.